Shantanu Nigam is the Managing Partner and Co-Founder of SeedToB Capital. See sector focus and contact routes.
Shantanu Nigam is the Managing Partner and Co-Founder of SeedToB Capital, an Atlanta-based venture firm he launched in 2020 after serving as CEO of Jvion, a clinical prescriptive AI company he scaled before its 2018 acquisition. His investment thesis focuses exclusively on early-stage healthcare technology companies that leverage artificial intelligence to deliver clinical impact, targeting Seed and Series A rounds primarily in the U.S. market with ARR of $1M+. SeedToB typically makes initial checks between $500,000 and $1.5 million and structures support to provide follow-on capital through the early stage to help startups reach Series B. Notable portfolio companies include Shimmer, an AI-enabled ADHD platform; Angel Eye, which uses AI for neonatal and pediatric care; Feel, a mental health diagnosis tool; and Moonlight Therapeutics, an allergy treatment startup. Nigam distinguishes his approach by emphasizing that AI pilots must demonstrate significant ROI beyond incremental value to justify commercial deployment, warning founders against treating pilots as science projects. He holds a Bachelor of Engineering from the Indian Institute of Technology
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Atlanta.
Investors like Shantanu Nigam · Full investor directory · Investor access · Company funding database